BL

Babu Lal Gupta

Active Director Director DIN 00571809
DIN 00571809 First appointment Aug 1998 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 1998
Shareholding value •••• Premium profile

About Babu Lal Gupta

Data last updated:

Babu Lal Gupta is a Director at Rajesh Pharma Private Limited (since 1998). The company operates in Pharma. Rajesh Pharma Private Limited reported revenue of ₹10.62 Cr (FY 2025).

DIN 00571809
Primary Designation Director
Industry Pharma
First Appointment 28 Aug 1998
Oldest Company Age 28 yrs
Largest company Rajesh Pharma Private Limited · ₹10.62 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Rajesh Pharma Private Limited U24232RJ1998PTC015062
Director28 Aug 19981998₹10.62 Cr (FY 2025)Active

Board colleagues of Babu Lal Gupta

Directorship timeline

Open interactive timeline →
Rajesh Pharma Private Limited
Premium access

Shareholding and investment profile for Babu Lal Gupta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Babu Lal Gupta

Babu Lal Gupta currently holds 1 directorship: Rajesh Pharma Private Limited (Director, since 28 Aug 1998, revenue ₹10.62 Cr (FY 2025)).

Babu Lal Gupta was first appointed on 28 Aug 1998 as Director at Rajesh Pharma Private Limited.

The current boards of Babu Lal Gupta's companies include Abhay Kotwal (Rajesh Pharma Private Limited), Akshay Kotwal (Rajesh Pharma Private Limited), Rajesh Gupta (Rajesh Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available